USP hosts international exchange on public quality standards for medicines and foods

Read more

Glenmark Generics receives final ANDA approval for Riluzole tablets

Read more

DPCO 2013: A fair move or a misstep?

Read more

‘’Drug price controls aren’’t the only solution’’

Read more

‘’Adverse impact of DPCO will be significant on OPPI member companies’’

Read more

‘‘The paradigm shift from cost-based pricing to market-based pricing has been long overdue’’

Read more

‘A win-win policy for all stakeholders’

Read more

‘’DPCO 2013 will equally affect domestic as well multinational pharma companies’’

Read more

‘’Longer-term growth prospects’’

Read more

‘‘This pricing policy would help on affordability issue’’

Read more